CMS approves Medicaid waivers to treat substance use disorders
The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders. Both states will receive Medicaid matching funds for treatment in facilities that meet the definition of an institution for mental diseases, which include hospitals and other residential treatment facilities with more than 16 beds that are primarily engaged in diagnosis, treatment or care of persons with mental diseases. CMS outlined additional waiver opportunities last November for states to treat SUDs and mental illness.
Related News Articles
Headline
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18…
Headline
The AHA April 23 released a blog responding to a report issued April 22 by Paragon Health Institute. The blog highlights how the report relies on a long list…
Blog
In think‑tank reports, like the one released this week by Paragon Health Institute, hospitals are often reduced to abstractions — payment rates, charts,…
Headline
Americans across 43 states enrolled in health plans from the nation’s four largest commercial health insurers face potential disparities in finding in-network…
Headline
The Centers for Medicare and Medicaid Services April 8 issued guidance on implementing a provision within the reconciliation bill passed in July 2025 regarding…
Headline
The Centers for Medicare & Medicaid Services April 2 announced the release of new data on health care utilization and prices at the provider and service…